# Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma

> **NCT00991991** · — · TERMINATED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 5 (actual)

## Conditions studied

- Melanoma (Skin)

## Interventions

- **GENETIC:** gene expression analysis
- **GENETIC:** polymerase chain reaction
- **GENETIC:** polymorphism analysis
- **OTHER:** matrix-assisted laser desorption/ionization time of flight mass spectrometry
- **OTHER:** medical chart review

## Key facts

- **NCT ID:** NCT00991991
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Not enough tissue for analysis
- **Last updated:** 2016-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00991991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00991991, "Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00991991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*